Author: Editor

Susan Monarez, President Donald Trump’s nominee to be the Director of the Centers for Disease Control and Prevention (CDC), testifies during her confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions in the Dirksen Senate Office Building on June 25, 2025 in Washington, DC. Kayla Bartkowski | Getty ImagesCenters for Disease Control and Prevention Director Susan Monarez has left the role just weeks after being sworn in, the Health and Human Services department said on Wednesday. In a post on X, the department said Monarez is longer director and thanked her for “her dedicated service to the American…

Even though the One Big Beautiful Bill Act made substantial changes in the Tax Code, one area where that may not be seen so much is in terms of simplification, according to a new study.The study, released Wednesday by the Tax Foundation, estimated the total costs for taxpayers to comply with the Tax Code this year will reach $536 billion, or nearly 1.8% of gross domestic product.Billions of taxpayer hours and dollars are spent on individual tax forms (over 2.1 billion hours at a total annual cost of $146.9 billion), but that accounts for less than 28% of the total…

Government contractors are feeling the revenue effects of executive orders from the Trump administration and cuts from the Department of Government Efficiency, according to a new survey.The report, from CohnReznick, a Top 25 Firm based in New York, found that approximately 40% of the 1,200 contractors polled say they have been directly impacted by the administration’s executive orders, while one in three of the contractors say they have been affected by DOGE-related orders. Nearly 40% of them have developed new policies or procedures for handling stop work orders One out of three of the contractors polled expressed positive feelings about their…

Pfizer’s Covid vaccine Comirnaty, seen at a CVS Pharmacy in Eagle Rock, California, Sept. 14, 2023.Irfan Khan | Los Angeles Times | Getty ImagesThe Food and Drug Administration on Wednesday approved the latest round of Covid vaccines in the U.S., but set new limits on who can get them.The agency ended its broader authorization of the shots, only clearing them for people at higher risk of severe illness. That includes those 65 and up and younger adults with at least one underlying condition that puts them at higher risk.The move could complicate access to the shots for millions of Americans,…